• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    NewGen Announces Planned $30 Million Strategic Investment in Solana Digital Asset Staking

    6/2/25 8:30:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care
    Get the next $NIVF alert in real time by email

    BANGKOK, June 02, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced plans to invest US$30 million in staking the digital asset Solana, marking a substantial expansion of the company's digital asset investment strategy. The investment will be funded through existing credit facilities of US$26 million and US$100 million with ATW and White Lion, respectively.

    Solana is recognized as one of the leading blockchain platforms, known for its high-speed transaction processing capabilities and growing ecosystem of decentralized applications. Solana's staking mechanism allows token holders to earn rewards derived from the network's inflation mechanism while simultaneously supporting network security and decentralization. By aligning with Solana, NewGen is strategically positioning to harness the power of a platform that is shaping the future of decentralized technology, offering immense potential for growth and innovation.

    This strategic move builds upon NewGen's initial entry into the digital assets space with a US$1 million Bitcoin investment completed in December 2024. The decision underscores management's continued confidence in the long-term potential of blockchain-based assets and decentralized finance protocols. As part of its expanded digital asset strategy, the Company plans to establish a dedicated subsidiary focused specifically on digital asset operations and investments, providing enhanced operational focus and strategic flexibility as NewGen forges ahead.

    Mr. Siu Wing Fung Alfred, Founder, Chairman, and CEO of NewGen, commented, "This investment represents a natural evolution of our digital asset strategy and positions us strategically within the burgeoning digital assets space. The decision to scale our investment from our initial $1 million Bitcoin position to this substantial $30 million Solana commitment reflects our growing conviction in digital assets as a legitimate asset class. We believe Solana's robust ecosystem and staking opportunities provide compelling value creation potential for our shareholders while diversifying our investment portfolio in this transformative technology sector, and we are eager to reap the potential rewards of this staking."

    About NewGen

    NewGen is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. With a mission to aid couples and individuals in building families regardless of fertility challenges, NewGen has dedicated itself to creating increased access to infertility treatment and providing comprehensive fertility services for its customers. NewGen's management team collectively has over a decade of experience in the fertility industry. NewGen's clinics are located in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions, respectively. To learn more, visit www.newgenivf.com. The information contained on, or accessible through, NewGen's website is not incorporated by reference into this press release, and you should not consider it a part of this press release.

    Forward-Looking Statements

    This press release contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements generally are identified by the words "believe," "project," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result," and similar expressions. Without limiting the generality of the foregoing, the forward-looking statements in this press release include descriptions of the Company's future commercial operations, business strategy, and financial condition. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, such as (i) extreme volatility in the digital asset market; (ii) regulatory uncertainty regarding the classification and treatment of digital assets; (iii) technological vulnerabilities specific to the Solana blockchain, including network outages, transaction failures, or security breaches; (iv) concentration risk from holding a single digital asset; (v) liquidity constraints impacting the ability to execute large transactions; (vi) operational risks related to custody, staking, or transaction execution; (vii) competition from alternative blockchain protocols; (viii) reputational, legal, or financial harm resulting from ecosystem malfunctions or third-party actions; and (ix) constraints in accessing or maintaining credit facilities necessary to fund the investment under the Company's existing facility agreements. You should carefully consider the foregoing factors and the other risks and uncertainties described in the Company's annual report on Form 20-F and other documents filed or to be filed by the Company with the SEC from time to time, which could cause actual events and results to differ materially from those contained in the forward-looking statements. Copies of these documents are available on the SEC's website, www.sec.gov. All information provided herein is as of the date of this press release, and the Company undertakes no obligation to update any forward-looking statement, except as required under applicable law.

    Investor Relations Contact

    ICR, LLC

    Robin Yang

    Phone: +1 (212) 537-4406

    Email: [email protected]



    Get the next $NIVF alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NIVF

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $NIVF
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    NewGen Filed 2025 Annual Report on Form 20-F

    BANGKOK, April 01, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2025, with the U.S. Securities and Exchange Commission (the "SEC"). The annual report can be accessed on the Company's investor relations website at https://investors.newgenivf.com. About NewGenIVF Group LimitedNewGenIVF Group is a tech-forward, diversified, multi-jurisdictional high-growth entity capitalizing on emerging opportunities across real estate development, digital asset innovation and reproductive health solutions. Th

    4/1/26 7:00:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    NewGen Signs MOU with Women in Web3 Hong Kong to Launch Regional Women's Health Awareness Initiative

    BANGKOK, March 02, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group (NASDAQ:NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today announced that it has entered into a Memorandum of Understanding ("MOU") with Women in Web3 Hong Kong Limited ("WiW3"), a leading community organization dedicated to advancing women and their allies in Hong Kong's Web3 ecosystem. Under the MOU, NewGen and WiW3 intend to collaborate on a co-branded public awareness and education campaign anchored by the NewGen manifesto and petition, with a primary focus on women's health literacy. The campaign will spotlight themes such as the urgency of improved education on women's health, the impa

    3/2/26 8:30:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    NewGen Provides Recap of Strategic Progress as Diversification Fuels Success, Positions Company for Breakout Year

    BANGKOK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group (NASDAQ:NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today outlined its remarkable financial and operational transformation, positioning the Company for significant value creation in 2026 and beyond. Over the past year, NewGen has successfully executed an extensive strategic pivot, building a robust balance sheet and a dynamic portfolio of high-growth international ventures. NewGen has completed a decisive corporate transformation, strengthening its foundation for accelerated growth. Through a proactive capital management strategy and strategic asset deployment, the Company has dramatically i

    2/24/26 8:30:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    $NIVF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Siu Wing Fung Alfred

    3 - NewGenIvf Group Ltd (0001981662) (Issuer)

    3/31/26 6:35:06 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 3 filed by new insider Fong Hei Yue Tina

    3 - NewGenIvf Group Ltd (0001981662) (Issuer)

    3/27/26 6:31:07 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 3 filed by new insider Ching Chan Florianna Ann Chi Wan

    3 - NewGenIvf Group Ltd (0001981662) (Issuer)

    3/27/26 6:29:39 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    $NIVF
    SEC Filings

    View All

    SEC Form 20-F filed by NewGenIvf Group Limited

    20-F - NewGenIvf Group Ltd (0001981662) (Filer)

    3/31/26 5:29:44 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    SEC Form EFFECT filed by NewGenIvf Group Limited

    EFFECT - NewGenIvf Group Ltd (0001981662) (Filer)

    3/16/26 12:15:12 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 424B3 filed by NewGenIvf Group Limited

    424B3 - NewGenIvf Group Ltd (0001981662) (Filer)

    3/13/26 8:01:02 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    $NIVF
    Leadership Updates

    Live Leadership Updates

    View All

    NIVF Appoints Award-Winning Web3 Leader Joshua Chu to Spearhead Tokenization Strategy and Formally Engages Evident Capital to Launch Up to USD 30 Million in Tokenized Bonds by Q1, Outlining 2026 Value Catalysts

    BANGKOK, Jan. 21, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (("NewGen" or the "Company, NASDAQ:NIVF), a technology-driven company building a diversified ecosystem across fertility technology, digital assets, and real estate development, today announced the appointment of award-winning Web3 legal and regulatory specialist Joshua Chu as Senior Counsel to lead the Group's tokenization strategy, alongside the formal engagement of Evident Capital, Hong Kong's first fully integrated, SFC-licensed tokenization and alternative assets platform, to support the launch of NIVF's inaugural tokenized bond issuance of up to USD 30 million targeted for completion by the first quarter of 2026. As S

    1/21/26 8:30:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    NewGenDigital Appointed as SAXA Inc.'s Agent for Tokenization of US$100 Million of Gold-backed Assets

    Service agreement with SAXA, Inc. appoints NewGenDigital as SAXA's worldwide tokenization agent, strengthening cooperation between the two companies ahead of proposed reverse merger Value of tokenized assets could be expanded to US$1 billion under the terms of the agreement; NewGenDigital to earn 5% commission on assets sold BANGKOK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a tech-forward, diversified, multi-jurisdictional high-growth entity transforming industries through innovative solutions across real estate development, digital asset management and reproductive health solutions, today announced that its subsidiary, NewGenD

    11/5/25 9:00:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director

    Company Granted Request to Continue its Listing on NasdaqAppoints Thorain Ko to Lead Business Development Initiatives BANGKOK, Feb. 20, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that the Nasdaq Hearings Panel (the "Panel") has granted the Company's request for continued listing on The Nasdaq Stock Market, subject to specific conditions. Additionally, the Company announced the appointment of Mr. Thorain Ko as Business Development Director to drive its expansion initiatives. Nasdaq Listing UpdateThe Pane

    2/20/25 6:00:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    $NIVF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by NewGenIvf Group Limited

    SC 13G - NewGenIvf Group Ltd (0001981662) (Subject)

    12/5/24 8:23:57 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13G filed by NewGenIvf Group Limited

    SC 13G - NewGenIvf Group Ltd (0001981662) (Subject)

    11/13/24 9:19:27 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13G filed by NewGenIvf Group Limited

    SC 13G - NewGenIvf Group Ltd (0001981662) (Subject)

    10/10/24 3:39:26 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care